EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy

Flávia Siqueira Cunha, Tania Aparecida Sartori Sanchez Bachega, Elaine Maria Frade Costa, Vinicius Nahime Brito, Leonardo Azevedo Alvares, Valéria Aparecida Costa-Hong, Renata Gomes Sanches Verardino, Maria Helena Palma Sircili, Berenice Bilharinho de Mendonça, Luiz Aparecido Bortolotto, Sorahia Domenice iD

Journal of the Endocrine Society · 06.03.2023 · 7 (5)

DOI: 10.1210/jendso/bvad040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 17.03.2023. Verfasst von Flávia Siqueira Cunha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Disciplina de Endocrinologia e Metabologia, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clinicas HCFMUSP, Faculdade de Medicina…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment.

Objective

To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid–femoral pulse wave velocity (cf-PWV).

Methods

A cross-sectional case–control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 ± 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group.

Results

The cf-PWV after long-term testosterone therapy was significantly higher in TM (7.4 ± 0.9 m/s; range 5.8-8.9 m/s) than in cisgender men (6.6 ± 1.0 m/s; range 3.8-9.0 m/s, P < .01) and cisgender women controls (6.9 ± .9 m/s; range 4.8-9.1 m/s, P = .02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group.

Conclusion

The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended.

Schlagwörter

Stichwörter der Autor:innen

arterial stiffnesscarotid–femoral pulse wave velocityfemale to male transsexualtestosteronetransgender man

Autor:innen und Institutionen

  • Disciplina de Endocrinologia e Metabologia, Laboratório de Hormônios e Genética Molecular/LIM42, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, 05403-900 São Paulo, SP, Brazil.
  • Centro Universitário São Camilo, Curso de Medicina, Departamento de Endocrinologia, 04264-030 São Paulo, SP, Brazil.
  • Unidade de Hipertensão Arterial do Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, 05403-900 São Paulo, SP, Brazil.

ORCID-Profile: Sorahia Domenice

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Cunha, F. S., Bachega, T. A. S. S., Costa, E. M. F., Brito, V. N., Alvares, L. A., Costa-Hong, V. A., Verardino, R. G. S., Sircili, M. H. P., de Mendonça, B. B., Bortolotto, L. A., & Domenice, S. (2023). Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy. Journal of the Endocrine Society, 7(5). https://doi.org/10.1210/jendso/bvad040

Vancouver

Cunha FS, Bachega TASS, Costa EMF, Brito VN, Alvares LA, Costa-Hong VA, et al. Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy. Journal of the Endocrine Society. 2023;7(5). doi:10.1210/jendso/bvad040

BibTeX
@article{Cunha2023,
  author = {Cunha, Flávia Siqueira and Bachega, Tania Aparecida Sartori Sanchez and Costa, Elaine Maria Frade and Brito, Vinicius Nahime and Alvares, Leonardo Azevedo and Costa-Hong, Valéria Aparecida and Verardino, Renata Gomes Sanches and Sircili, Maria Helena Palma and de Mendonça, Berenice Bilharinho and Bortolotto, Luiz Aparecido and Domenice, Sorahia},
  title = {Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy},
  journal = {Journal of the Endocrine Society},
  year = {2023},
  volume = {7},
  number = {5},
  doi = {10.1210/jendso/bvad040}
}
Kostenlos starten →